This is a public record generated listing.
Assets of Pharmaceutical Company
Listing Information
Attachments
Assets of Pharmaceutical Company
Price: Not Specified
Other Item Info
Item #: debke_163348
Created: 09/06/2016
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Date: Mon. Nov 14, 2016
Created: 09/06/2016
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Date: Mon. Nov 14, 2016
Seller Info
Marion M. Quirk
Debtor's Attorney
500 Delaware Avenue, Suite 1410
Wilmington, DE 19801
302-652-3131
Debtor's Attorney
500 Delaware Avenue, Suite 1410
Wilmington, DE 19801
302-652-3131
Bankruptcy Info
Case #: 1:16-bk-11074
Case Title: NephroGenex, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Case Title: NephroGenex, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Description
Sale of assets of NephroGenex, Inc. which includes:
- the Purchaser shall acquire all the Contracts and all rights thereunder (the "Assigned Contracts")
- the Purchaser shall acquire all rights and remedies under all warranties, representations and guarantees made by suppliers, manufacturers and contractors;
- the Purchaser shall acquire all inventory, finished goods, works in process, raw materials and packaging materials;
- the Purchaser shall acquire all (i) patents and patent applications, including provisionals, continuations, continuations-in-part, divisionals, substitutions, reissues, reexaminations and any extensions and supplementary protection certificates; (ii) trademarks, service marks, trade dress, trade names, logos, slogans, Internet domain names (except nephrogenex.com) and other similar designations of source or origin, together with the goodwill symbolized by, and any registrations and applications for, the foregoing; (iii) copyrights and database rights, and any copyright registrations and applications; (iv) trade secrets, including trade secret rights in inventions, discoveries, know-how, proprietary processes, formula, protein sequences, standards for comparison, research and development information, clinical data, cell lines, dedicated toll free product lines, manufacturing technology and data, marketing and sales information, customer lists and supplier lists; and (v) any other intellectual property rights recognized in any relevant jurisdiction (collectively, "Intellectual Property"), including such of the foregoing as are listed or described;
- the Purchaser shall acquire all rights under non-disclosure, confidentiality, invention and Intellectual Property assignment agreements with current or former employees and agents of the Seller or with third parties;
- the Purchaser shall acquire to the extent transferable, all Permits and all pending applications therefor;
- to the extent transferable, the Purchaser shall acquire all insurance policies set forth and rights thereunder relating to the Acquired Assets;
- other than as set forth, the Purchaser shall acquire all books and records relating to the Acquired Assets;
Financial Overview
Income and Expenses ($)
months
Revenue/Gross Income:
Total Expenses:
Cash Flow:
Asset and Liability Summary ($)
Receivables:
Inventory:
FF&E:
Real Estate:
Total Assets:
Liabilities to assume:
Additional Details
- Auction Time: 10:00 a.m.
- Sale hearing on November 17, 2016
- Last Date to Respond: October 18, 2016